Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-010076
Filing Date
2025-04-03
Accepted
2025-04-03 19:22:11
Documents
1
Period of Report
2025-04-01

Document Format Files

Seq Description Document Type Size
1 form4-04032025_110406.html 4  
1 form4-04032025_110406.xml 4 7086
  Complete submission text file 0001415889-25-010076.txt   8901
Mailing Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960
Business Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960 551-321-2234
Whitehawk Therapeutics, Inc. (Issuer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AADI BIOSCIENCE, INC. 17383 SUNSET BLVD, SUITE A250 PACIFIC PALISADES CA 90272
Business Address
Lennon David James (Reporting) CIK: 0001995275 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38560 | Film No.: 25811533